CI
OVID icon

Cowen Inc’s Ovid Therapeutics OVID Stock Holding History

Cowen Inc’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.8M Sell
972,260
-129,154
-12% -$231K 0.13% 122
2019
Q1 		$1.95M Buy
1,101,414
+250,000
+29% +$625K 0.21% 78
2018
Q4 		$2.06M Buy
851,414
+143,771
+20% +$656K 0.23% 96
2018
Q3 		$4.01M Buy
707,643
+45,000
+7% +$341K 0.37% 71
2018
Q2 		$5.17K Buy
+662,643
New +$5.69M 0.22% 81
2017
Q4 		– Sell
-10,211
Closed -$88K – 335
2017
Q3 		$88K Buy
+10,211
New +$85K ﹤0.01% 211

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cowen Inc's OVID Position: Q2 2019 in Review

Cowen Inc reduced its Ovid Therapeutics (OVID) stake by 12% in Q2 2019, selling an estimated $231K and leaving 972,260 shares worth $1.8M. The position accounts for 0.13% of the portfolio, ranked #122.

Cowen Inc first reported a position in OVID in Q3 2017 and has held it in 6 quarters since. The position peaked at $4.01M in Q3 2018. 35 funds tracked by Wall St. Rank hold OVID as of Q2 2019.

  • Cowen Inc held 972,260 shares of Ovid Therapeutics worth $1.8M as of Q2 2019.
  • Cowen Inc sold 129,154 Ovid Therapeutics shares in Q2 2019, an estimated $231K.
  • Ovid Therapeutics made up 0.13% of Cowen Inc's portfolio in Q2 2019, its #122 holding.
  • Cowen Inc first reported a position in Ovid Therapeutics in Q3 2017 and has held it in 6 quarters since.
  • Cowen Inc's Ovid Therapeutics position peaked at $4.01M in Q3 2018.
  • 35 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.